University of North Carolina, Chapel Hill, NC.
University of Michigan, Ann Arbor, MI.
J Clin Oncol. 2019 Nov 10;37(32):3042-3049. doi: 10.1200/JCO.19.01411. Epub 2019 Oct 1.
To understand the effect of patient preferences on thyroid cancer surveillance intensity.
Eligible patients diagnosed with thyroid cancer between January 1, 2014, and December 31, 2015, from the Georgia and Los Angeles County SEER registries were surveyed between February 2017 and October 2018 (N = 2,632; response rate, 63%). Patient reports on health care utilization in the past year and responses to the validated Medical Maximizer-Minimizer Scale were linked to SEER data in the 2,183 disease-free patients. Ordered logistic regression was performed using a cumulative logit with nonproportional odds.
Of disease-free patients, 31.6% were classified as minimizers, 42.5% as moderate maximizers, and 25.9% as strong maximizers. In the past year, 25.2%, 27.3%, and 38.5% of minimizers, moderate maximizers, and strong maximizers, respectively, had ≥ 4 doctor visits, and 18.3%, 24.9%, and 29.5%, respectively, had ≥ 2 neck ultrasounds. When controlling for age, sex, race and ethnicity, comorbidity, stage, and SEER site, strong maximizers (compared with minimizers) were significantly more likely to report ≥ 4 doctor visits (odds ratio [OR], 1.45; 95% CI, 1.10-1.92), ≥ 2 neck ultrasounds (OR, 1.58; 95% CI, 1.17-2.14), ≥ 1 radioactive iodine scan (OR, 1.73; 95% CI, 1.19-2.50), and ≥ 1 additional imaging study (OR, 2.06; 95% CI, 1.56-2.72).
Among patients with thyroid cancer who have been declared disease free, preference for a more maximal versus minimal approach to medical care is associated with increased number of physician visits and imaging tests. Because increased surveillance does not clearly correlate with improved outcomes, poses potential risks to patients, and contributes to increased healthcare costs, stronger consideration of the role of patient preferences is necessary when framing discussions on surveillance.
了解患者偏好对甲状腺癌监测强度的影响。
本研究纳入了 2014 年 1 月 1 日至 2015 年 12 月 31 日期间在佐治亚州和洛杉矶县 SEER 登记处诊断为甲状腺癌的患者,于 2017 年 2 月至 2018 年 10 月期间进行了调查(N=2632;应答率为 63%)。在 2183 例无疾病患者中,将患者过去一年的医疗保健利用情况报告和对经过验证的医疗最大化-最小化量表的回答与 SEER 数据相关联。使用累积对数比进行有序逻辑回归,非比例优势。
在无疾病患者中,31.6%的患者被归类为最小化者,42.5%的患者为中度最大化者,25.9%的患者为强烈最大化者。在过去的一年中,分别有 25.2%、27.3%和 38.5%的最小化者、中度最大化者和强烈最大化者进行了≥4 次就诊,分别有 18.3%、24.9%和 29.5%进行了≥2 次颈部超声检查。在控制年龄、性别、种族和民族、合并症、分期和 SEER 部位后,与最小化者相比,强烈最大化者更有可能报告进行了≥4 次就诊(优势比[OR],1.45;95%置信区间[CI],1.10-1.92)、≥2 次颈部超声检查(OR,1.58;95%CI,1.17-2.14)、≥1 次放射性碘扫描(OR,1.73;95%CI,1.19-2.50)和≥1 次额外成像研究(OR,2.06;95%CI,1.56-2.72)。
在被宣布无疾病的甲状腺癌患者中,对更积极(最大化)而非更消极(最小化)医疗方法的偏好与就诊次数和影像学检查次数的增加相关。由于增加监测并不能明确与改善结局相关,对患者存在潜在风险,并导致医疗保健费用增加,因此在制定监测讨论时,需要更强烈地考虑患者偏好的作用。